Healthcare • Biotechnology
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials.
The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
Company profile from EODHD, stored Nov 7, 2026.
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jul 2026filed Oct 28, 2026 | — | — | — | -$12.5M | -$12.3M |
| Apr 2026filed Jun 9, 2026 | — | — | — | -$7.6M | -$7.2M |
| Jan 2026filed Mar 10, 2026 | — | — | — | -$7.7M | -$7.4M |
| Oct 2025filed Dec 11, 2025 | — | — | — | -$11.7M | -$11.5M |
| Jul 2025filed Oct 16, 2025 | $225.3K | +894.0% | — | -$11.7M | -$11.1M |
| Apr 2025filed Jun 16, 2025 | — | — | — | -$8.7M | -$8.5M |
| Jan 2025filed Mar 12, 2025 | — | — | — | -$10.6M | -$9.3M |
| Oct 2024filed Dec 16, 2024 | — | — | — | -$7.2M | -$8.1M |
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jul 2026filed Oct 28, 2026 | — | — | — | -$35.6M | -$34.9M |
| Jul 2025filed Oct 16, 2025 | — | — | — | -$37.7M | -$36.5M |
| Jul 2024filed Oct 29, 2024 | — | — | — | -$33.3M | -$4.8M |
| Jul 2023filed Oct 25, 2023 | — | — | — | -$31.1M | -$27.1M |
| Jul 2022filed Oct 28, 2022 | — | — | — | -$19.6M | -$34.4M |
| Jul 2021filed Oct 29, 2021 | — | — | — | -$8.7M | -$17.3M |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched BCTX. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
789,493 shares short
+10,397 shares (+1.3%) vs Sep 30, 2026
10% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
779,096 shares short
-13,128 shares (-1.7%) vs Sep 15, 2026
9.9% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
792,224 shares short
+68,388 shares (+9.4%) vs Aug 31, 2026
10.1% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
723,836 shares short
+324,923 shares (+81.5%) vs Aug 14, 2026
9.2% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
398,913 shares short
-9,381 shares (-2.3%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
408,294 shares short
-39,784 shares (-8.9%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind BCTX’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
1 for 10 · reverse split
Effective Aug 25, 2025
Each 10 pre-split shares become 1 post-split share.
Source: EODHD
1 for 15 · reverse split
Effective Jan 29, 2025
Each 15 pre-split shares become 1 post-split share.
Source: EODHD
1 for 300 · reverse split
Effective Jan 2, 2020
Each 300 pre-split shares become 1 post-split share.
Source: EODHD
4 for 13 · reverse split
Effective Dec 3, 2014
Each 13 pre-split shares become 4 post-split shares.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if BCTX is in your portfolio and how much it contributes.
Sign inLoading market dates
0 smart-money holders: institutions with a high Holder IQ
Sentiment: unknown
No recent insider trades detected.
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 1
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.